Skip to main content

Rockwell Medical, Inc.

RMTI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001041024

In the last 90 days, Rockwell Medical, Inc. insiders filed 0 open-market purchases and 1 sale; 37 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Rockwell Medical, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of RMTI: Q1 2021 compared with Q2 2021
MeasureQ1 2021Of which not filed for Q2 2021Q2 2021Change
Holders92278−12
Shares22.0M82.2K16.5M−5.37M (−24.5%)
Value$25.4M$96.0K$15.0M−$10.3M (−40.7%)

2 institutions that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (12)

Institutions that held Rockwell Medical, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to RMTI in Q2 2021
InstitutionSharesValue% of portfolio
Russell Investments Group, Ltd.1,438,396$1.31M0.00%
Millennium Management LLC1,107,806$1.01M0.00%
Tibra Equities Europe Ltd366,900$334.0K0.10%
Ergoteles LLC177,384$161.0K0.00%
LMR Partners LLP37,473$34.0K0.00%
HighTower Advisors, LLC34,689$32.0K0.00%
Y-Intercept (Hong Kong) Ltd17,721$16.0K0.00%
Vectors Research Management, LLC12,486$11.0K0.00%
Cambridge Investment Research Advisors, Inc.10,945$10.0K0.00%
Beacon Pointe Advisors, LLC10,000$9.00K0.00%
Advisory Services Network, LLC80$00.00%
Beck Bode, LLC300$00.00%

Sold out (24)

Institutions that held Rockwell Medical, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Not filed for Q2 2021 yet (2)

Institutions that held Rockwell Medical, Inc. at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RMTI in Q1 2021 that haven't filed for Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
OneAscent Financial Services LLC41,111$48.0K
OneAscent Wealth Management LLC41,111$48.0K